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t has been reported that phosphoinositide 3-kinase (PI
3-kinase) and its downstream target, protein kinase B
(PKB), play a central role in the signaling of cell survival
triggered by neurotrophins (NTs). In this report, we have
 
analyzed the involvement of Ca
 
2
 
 
 
 and calmodulin (CaM)
in the activation of the PKB induced by NTs. We have
found that reduction of intracellular Ca
 
2
 
 
 
 concentration or
functional blockade of CaM abolished NGF-induced acti-
vation of PKB in PC12 cells. Similar results were obtained
in cultures of chicken spinal cord motoneurons treated
I
 
with brain-derived neurotrophic factor (BDNF). Moreover,
CaM inhibition prevented the cell survival triggered by
NGF or BDNF. This effect was counteracted by the tran-
 
sient expression of constitutive active forms of the PKB,
indicating that CaM regulates NT-induced cell survival
through the activation of the PKB. We have investigated the
mechanisms whereby CaM regulates the activation of
 
the PKB, and we have found that CaM was necessary for the
proper generation and/or accumulation of the products of
the PI 3-kinase in intact cells.
 
Introduction
 
Neurotrophins (NTs)* and their tyrosine kinase receptor,
Trk, are involved in the development, maintenance, and re-
pair of the nervous system (Lewin and Barde, 1996). NTs
include NGF, brain-derived neurotrophic factor (BDNF),
 
NT-3, and NT-4/5 (Davies, 1994). There is growing
evidences indicating that phosphoinositide 3-kinase (PI
3-kinase), one of the intracellular effectors activated by these
factors, plays a central role in the regulation of cell survival
in a wide variety of neuronal cell populations (Kaplan and
Miller, 2000).
The pathway that leads to the activation of the PI 3-kinase
after Trk activation begins with the autophosphorylation of
the receptor at the residue Tyr
 
490
 
 and the phosphorylation of
Shc (Obermeier et al., 1993; Hallberg et al., 1998). This al-
lows the recruitment to the membrane of several adaptor
proteins, which upon tyrosine phosphorylation interact with
and activate PI 3-kinase (Holgado-Madruga et al., 1997; Ya-
mada et al., 1997). Furthermore, it has been reported that
Ras cooperates in the activation of the PI 3-kinase, since
dominant negative forms of this GTPase inhibit PI 3-kinase
activity (Rodriguez-Viciana et al., 1994). PI 3-kinase cata-
lyzes the phosphorylation of the D3 hydroxyl group of the
inositol ring of phosphoinositides (PtdIns) (Czech, 2000).
PtdIns-3,4-P
 
2
 
 and PtdIns-3,4,5-P
 
3
 
 are the main products
generated and provide docking sites for pleckstrin homology
(PH) domains of effector proteins such as the Ser/Thr
protein kinase B (PKB), the cellular homologue of the
 
transforming oncogene 
 
v-Akt
 
 (Bellacosa et al., 1991; Coffer
and Woodgett, 1991; Jones et al., 1991). The interaction of
 
PtdIns-3,4-P
 
2
 
/PtdIns-3,4,5-P
 
3
 
 with PKB allows the transloca-
tion of the protein to the plasma membrane where it becomes
fully activated upon phosphorylation at two residues, Thr
 
308
 
and Ser
 
473
 
 (Alessi et al., 1996).
In a variety of cell systems, including neuronal cells, PKB
mediates an important part of the trophic signal derived
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from PI 3-kinase activation (Dudek et al., 1997; Philpott et
al., 1997; Crowder and Freeman, 1998). Several studies
have reported that PKB interferes with the cell death ma-
chinery phosphorylating and inactivating proteins that are
directly involved in the induction of apoptosis such as
GSK3
 
 
 
, BAD (a member of the Bcl-2 family of proteins), or
members of the Forkhead family of transcription factors in-
volved in the transcription of Fas ligand (Datta et al., 1999).
Bioelectrical activity cooperates with NTs in promot-
ing neuronal survival during development (Franklin and
Johnson, 1992). Neuronal activity exerts its trophic effects
by moderately increasing the intracellular Ca
 
2
 
 
 
 
 
concentra-
tion ([Ca
 
2
 
 
 
]
 
i
 
). Ca
 
2
 
 
 
 triggers the activation of similar signal-
ing pathways to those activated by NTs, mainly through the
Ca
 
2
 
 
 
 receptor protein calmodulin (CaM) (Finkbeiner and
Greenberg, 1996). Moreover, it has been reported that acti-
vation of Trk leads to a small and rapid increase of [Ca
 
2
 
 
 
]
 
i
 
(Pandiella-Alonso et al., 1986; Jiang and Guroff, 1997).
However, the involvement of Ca
 
2
 
 
 
 in the response of the
cells to the NTs has been poorly characterized. In the
present work, we show that CaM is necessary for the promo-
tion of cell survival triggered by NTs in PC12 cells and in
chicken spinal cord motoneurons (MTNs). Our results
demonstrate that this effect is mainly due to the regulation
of PKB activity. We provide evidence that CaM is necessary
to detect PtdIns-3,4-P
 
2
 
/PtdIns-3,4,5-P
 
3
 
 in the plasma mem-
brane of live cells thus providing a possible mechanism by
which CaM regulates PKB activity and cell survival.
Figure 1. Activation of PKB by NGF requires both Ca
2  and CaM. PC12 cells (A–E) or MTNs (F) were treated with BAPTA-AM (50  M), 
EGTA (5 mM), LY294002 (50  M), W5 or W7 (100  M), TFP (50  M), W13 or W12 (70  M, unless otherwise indicated), or with vehicle 
(Me2SO) and then stimulated for 5 min with NGF (50 ng/ml; A–E) or with BDNF (50 ng/ml; F) as indicated. (A and B) PKB was immunoprecip-
itated and kinase activity assayed with histone H2B as substrate (top panels and graphs). Equal amounts of immunoprecipitated PKB were 
checked by Western blot using a specific antibody against PKB (bottom panels). Radiolabeled spots were quantified and kinase activity ex-
pressed as fold induction over basal and represented as the mean   SEM of two independent experiments. **P value using the Student’s t test 
was  0.01 relative to the treatment with NGF alone. (C–F) Phosphorylation of the residues Thr
308 (top panels) and Ser
473 (middle panels) of 
PKB was analyzed by Western blot using specific phospho-antibodies. Protein loading was checked, reprobing the filters with specific anti-
bodies against total PKB, ERK, or  -tubulin as indicated (bottom panels). 
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Results
 
NT-induced PKB activation requires Ca
 
2
 
 
 
 and CaM
 
PKB is activated by NGF in PC12 cells through a mecha-
nism involving PI 3-kinase (Park et al., 1996; Andjelkovic et
al., 1998). We wanted to analyze the involvement of Ca
 
2
 
 
 
and CaM in this activation. For this, we chelated the
intracellular Ca
 
2
 
 
 
 using 1,2 bis(2-aminophenoxy) ethene
N,N,N
 
 
 
,N
 
 
 
-tetraacetic acid (BAPTA) or the extracellular
Ca
 
2
 
  
 
using EGTA, and then we analyzed the activation of
PKB after NGF stimulation. NGF induced a strong increase
Figure 2. NGF requires CaM to promote cell survival in PC12 cells. PC12 cells were serum starved and treated with NGF (10 ng/ml), 
LY294002 (20  M), W13 (30  M), or left untreated as indicated. After 15 h, cells were fixed, stained with Hoechst 33258, or subjected to a 
TUNEL assay. (A) Percentage of cells displaying typical nuclear apoptotic morphology. The values represent the mean   SEM of three indepen-
dent experiments. **P value using the Student’s t test was  0.01 relative to the treatment with NGF alone. (B) Representative photomicrographs 
showing the morphology of the nuclei of the cells in the different treatments. Arrowheads indicate the apoptotic nuclei. (C) Representative 
phase–contrast micrographs and TUNEL reaction of the same field of the cultures treated above. (D) PC12 cells were treated with W13 (30  M) 
and then stimulated for the indicated times with NGF (10 ng/ml). Phosphorylation of the residues Thr
308 (top panel) and Ser
473 (middle panel) of 
PKB was analyzed by Western blot using specific phospho-antibodies. Protein loading was checked, reprobing the filters with a specific anti-
body against  -tubulin (bottom panel). Bars: (B) 10  m; (C) 20  m. 
588 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
in PKB activity (
 
 
 
11-fold over basal) that was almost com-
pletely prevented by BAPTA (Fig. 1 A). In contrast, concen-
trations of EGTA that effectively block depolarization-
induced activation of extracellular signal–regulated kinase
(ERK) mitogen-activated protein (MAP) kinases (Egea et
al., 1999) did not significantly affect the activation of PKB
Figure 3. BDNF requires CaM to promote cell survival in MTNs. MTNs were starved of muscle extract and were treated with BDNF (10 ng/ml), 
W13 (30 mM), W12 (30 mM), or left untreated as indicated. (A) After 24 h, cells were counted, and survival was expressed as the percentage of cells 
remaining in each treatment. Graph shows the mean   SEM of three independent experiments. **P value using the Student’s t test was  0.01 
relative to the treatment with BDNF alone. (B) After 15 h, cells were fixed and subjected to a TUNEL assay and stained with Hoechst 33258. 
The percentage of cells displaying typical nuclear apoptotic morphology and the percentage of TUNEL-positive cells were evaluated and repre-
sented as the mean   SEM of two independent experiments. **P value using the Student’s t test was  0.01 relative to the treatment with BDNF 
alone. (C) Representative photomicrographs showing the morphology of the nuclei of the cells treated in B and stained with Hoechst 33258. 
Arrowheads indicate the apoptotic nuclei. (D) Representative photomicrographs showing TUNEL reaction and Hoechst staining of the same 
field of the cultures treated in B. (E) MTNs were treated with W13 (30  M) and then stimulated for 5 min with BDNF (10 ng/ml) as indicated. 
Phosphorylation of the residues Thr
308 (top panel) and Ser
473 (middle panel) of PKB was analyzed by Western blot using specific phospho-anti-
bodies. Protein loading was checked, reprobing the filters with a specific antibody against  -tubulin (bottom panel). Bars: (C) 10  m; (D) 40  m. 
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(Fig. 1 A). In parallel experiments, we observed that the
CaM antagonist W13 mimicked the effect of BAPTA on
NGF-induced PKB activity. As shown in Fig. 1 B, increas-
ing concentrations of W13 blocked the activation of PKB in
a dose-dependent manner. At 70 mM, W13 reached an in-
hibitory effect similar to that observed with the specific PI
3-kinase inhibitor LY294002 (Vlahos et al., 1994) (Fig. 1
B). At this concentration, the effect of W13 was specific,
since the same concentration of W12, a less active structural
analogue (W13
 
IC50 
 
 
 
 68 
 
 
 
M versus W12
 
IC50
 
 
 
 
 
 260 
 
 
 
M;
Hidaka and Tanaka, 1983), did not affect NGF-induced
PKB activity (Fig. 1 B). Moreover, 70 
 
 
 
M of W13 effec-
tively inhibits the autophosphorylation of CaMKII induced
by ionomycin in PC12 cells, a well-known Ca
 
2
 
 
 
/CaM-
dependent process (unpublished data; Egea et al., 2000).
PKB activity is mainly induced by phosphorylation of the
residues Thr
 
308
 
 and Ser
 
473
 
 (Alessi et al., 1996). We used spe-
cific phospho-antibodies against each of these two residues
to check the phosphorylation of PKB upon NGF stimula-
tion in the presence of Ca
 
2
 
 
 
 chelators or CaM antagonists.
According to the experiments of kinase activity shown
above, BAPTA (Fig. 1 C) and W13 but not W12 (Fig. 1 D)
blocked the phosphorylation of both residues. Moreover, the
inhibition exerted by W13 was sustained over the time of
treatment (Fig. 2 D). Other CaM inhibitors, such as W7
(100 
 
 
 
M) or the W13 structurally unrelated trifluoperazine
dimaleate (TFP; 50 
 
 
 
M), displayed similar effects as those
observed with W13 (Fig. 1 E). In these experiments, we also
included the CaM inhibitor W5 as a control of the unspe-
cific effects of W7 (W7
 
IC50
 
 
 
 
 
 28 
 
 
 
M versus W5
 
IC50
 
 
 
 
 
 240
 
 M; Hidaka and Tanaka, 1983). As shown in Fig. 1 E, W5
did not significantly affect PKB phosphorylation, confirm-
ing the specificity of W7 effects. Finally, as expected from
the kinase activity assay shown in Fig. 1 A, EGTA did not
modify the phosphorylation of the PKB induced by NGF
(unpublished data).
Figure 4. Constitutively active forms of PKB pre-
vent the cell death induced by CaM antagonists in 
NT-maintained cultures. PC12 cells (A and B) or 
MTNs (C) were transiently cotransfected with 
pEGFP and pCMV5-HA-PKB
T308D/S473D (PKBDD) or 
pSG5-Gag-PKB or the empty vector. (A and B) 
PC12 cells were serum starved and treated with 
NGF (10 ng/ml), W13 (30  M), or left untreated as 
indicated. After 15 h, cells were fixed and stained 
with Hoechst 33258. The percentage of apoptotic 
cells scored into the EGFP-positive cell population 
was evaluated and represented as the mean   SEM 
of three independent experiments. (C) MTNs were 
treated with BDNF (10 ng/ml), W13 (30  M), 
LY294002 (20  M), or left untreated as indicated. 
After 24 h, EGFP-positive cells were counted, and 
survival was expressed as the percentage remain-
ing of EGFP-positive cells in each treatment. The 
graph shows the mean   SEM of three independent 
experiments. **P value using the Student’s t test 
was  0.01 when comparing the cultures trans-
fected with pCMV5-HA-PKB
T308D/S473D or pSG5-
Gag-PKB with those transfected with the empty 
vector in each treatment (A–C).590 The Journal of Cell Biology | Volume 154, 2001
We have reported previously that chicken spinal cord
MTNs can be maintained in culture in the presence of BDNF
(Becker et al., 1998). Like PC12 cells treated with NGF, the
stimulation of cultured MTNs with BDNF phosphorylates
and activates PKB in a PI 3-kinase–dependent manner (Dol-
cet et al., 1999). In this context, we analyzed whether MTNs
also required CaM to activate PKB. As shown in Fig. 1 F,
W13 inhibited both Thr
308 and Ser
473 phosphorylations to a
similar extent to that observed with LY294002 (Fig. 1 F).
CaM antagonists block NT-induced cell survival
The survival induced by NGF in PC12 cells can be strongly
attenuated by inhibitors of PI 3-kinase (Yao and Cooper,
1995) or by treatments that block PKB activity (Weihl et al.,
1999; Salinas et al., 2000). Therefore, we wanted to analyze
whether the inhibition of PKB induced by CaM antagonists
had any effect on cell survival. For this purpose, we main-
tained PC12 cell cultures in the presence of NGF (10 ng/ml)
plus W13 (30 mM) or LY294002 (20 mM) for 15 h. At the
end of the treatments, cells were fixed and stained with
Hoechst 33258 or subjected to a TdT-mediated dUTP nick
end labeling (TUNEL) assay. As shown in Fig. 2 A, the per-
centage of cells that display typical morphological apoptotic
nuclei in the cultures treated with NGF plus W13 increased
significantly when compared with cultures treated with NGF
alone. Values were similar to those obtained in cultures
maintained without any trophic support or in cultures
treated with NGF plus LY294002. The values of apoptotic
nuclei in W13 treatments were indistinguishable from those
observed in starved cultures or in cultures treated with NGF
plus LY294002 (Fig. 2 B). Similarly, W13 increased the
number of TUNEL-positive cells in cultures maintained
with NGF (5.98    1.04%) when compared with cells
treated with NGF alone (3.26   0.37%), reaching similar
values to those observed in cultures treated with NGF plus
LY294002 (7.01   0.84%). (In these experiments, the per-
centage of TUNEL-positive cells in cultures without trophic
support was 9.96   1.17) [Fig. 2 C].) The concentration of
W13 used in these experiments did not increase the cell
death observed in trophic support-starved cultures, suggest-
ing that W13 was specifically interfering with the intracellu-
lar signaling pathway involved in NGF-induced cell survival
(Fig. 2 A). As a control, we checked whether the concentra-
tion of W13 used in the experiments of survival (30  M) in-
hibited the activation of PKB induced by 10 ng/ml NGF. As
Figure 5. Regulation by CaM of the 
NT-induced activation of PKB occurs 
downstream of PI 3-kinase. PC12 cells 
were treated with 70 mM of W12 or 
W13 and then stimulated for 5 (A–C) or 
2 min (D) with NGF (50 ng/ml) as indi-
cated. (A) TrkA was immunoprecipitated 
and tyrosine phosphorylation of the 
receptor analyzed by Western blot using 
an anti–P-Tyr antibody. (B) Shc proteins 
were immunoprecipitated and analyzed 
by Western blot with an anti–P-Tyr anti-
body (top panels). Position of the 66-, 
52-, and 48-kD isoforms of Shc is indi-
cated. Protein loading was checked, re-
probing the filters with a specific antibody 
against total Shc (bottom panels). (C) Ac-
tive Ras (Ras-GTP) was precipitated with 
GST–RBD coupled to glutathione-
Sepharose, and Ras was detected by 
Western blot using a pan-Ras antibody. 
(D) PI 3-kinase activity was assayed in 
P-Tyr immunoprecipitates using L- -phos-
phatidylinositol as substrate (top panel). 
Radiolabeled spots were quantified and 
kinase activity expressed as fold induc-
tion over basal. Bottom graph represents 
the mean   SEM of two independent 
experiments. (E) MTNs were treated with 
70  M of W13, stimulated for 2 min with 
BDNF (50 ng/ml), and PI 3-kinase activ-
ity assayed as in D (top panel). The same 
cell extracts were analyzed by Western 
blot using a specific phospho-antibody 
against the residue Ser
473 of PKB (middle 
panel). Protein loading was checked rep-
robing the filter with a specific antibody 
against  -tubulin (bottom panel). Calmodulin modulates neuronal survival | Egea et al. 591
shown in Fig. 2 D, this concentration of the drug induced an
effective and sustained inhibition of both Thr
308 and Ser
473
phosphorylations of PKB.
We next analyzed the involvement of CaM in cell sur-
vival in a primary culture of neurons, and for this we used
chicken MTNs maintained with BDNF. This experimental
paradigm has several similarities with PC12 cells main-
tained with NGF. For example, we have demonstrated pre-
viously that BDNF-induced MTN survival is prevented by
LY294002 (Dolcet et al., 1999), and here we have shown
that the activation of PKB triggered by BDNF requires Ca
2 
and CaM (Fig. 1 F). Therefore, MTNs were treated with
BDNF (10 ng/ml) plus W13 (30  M), and cell survival was
analyzed after 24 h. Our experiments showed that W13 but
not W12 prevented the BDNF-induced MTN survival
without increasing the cell death of parallel control cultures
maintained in basal media without BDNF (Fig. 3 A). This
effect correlated with a significative increase in the number
of TUNEL-positive cells (Fig. 3, B and D) and in the num-
ber of the cells displaying typical morphological apoptotic
nuclei (Fig. 3 B). As shown in Fig. 3 C, the morphology of
the apoptotic nuclei in W13 treatments was indistinguish-
able from that observed in starved cultures or in cultures
treated with BDNF plus LY294002. Fig. 3 E shows that 30
 M of W13 effectively blocked the phosphorylation of PKB
induced by 10 ng/ml BDNF.
Constitutive active forms of PKB prevent the cell death 
induced by CaM antagonists
The results above show a good correlation between inhibition
of PKB and inhibition of cell survival induced by CaM antag-
onists. To test whether the prevention of cell survival triggered
by these inhibitors was due to the inhibition of PKB, we
transfected PC12 cells and MTNs with one of the two types
of constitutive active forms: Gag-PKB, a constitutive plasma
membrane-bound protein, and HA-PKB
T308D/S473D, a tagged
form of the protein that carries a mutational acidic charge in
addition to its main regulatory phosphorylation sites (Burger-
ing and Coffer, 1995; Alessi et al., 1996). The transfected cul-
tures were then treated with the corresponding NT plus W13,
and at the end of the treatments cell survival was evaluated
and compared with control cultures transfected with the
empty vector. Results showed that Gag-PKB protected both
PC12 cells and MTNs from the cell death induced by trophic
factor withdrawal (Fig. 4, A and C, untreated cultures). Simi-
lar effects displayed HA-PKB
T308D/S473D in serum-starved
PC12 cells (Fig. 4 B, untreated cultures). Interestingly, Gag-
PKB and HA-PKB
T308D/S473D were also able to prevent the cell
death triggered by W13 in cultures of PC12 maintained with
NGF (Fig. 4, A and B, respectively). Accordingly, the cell
death induced by W13 in BDNF-maintained MTNs was
strongly reduced in Gag-PKB– (Fig. 4 C) and in HA-
PKB
T308D/S473D-transfected cultures (unpublished data) when
compared with the empty vector–transfected cultures. These
results indicate that CaM antagonists exert their effect on NT-
induced survival, mainly inhibiting the activation of PKB.
CaM does not modulate early signaling events involved 
in PKB activation
The results presented in Fig. 1 indicate that Ca
2  and CaM
regulate upstream event(s) involved in the phosphorylation
and activation of PKB. We have shown previously that inhi-
bition of CaM does not affect the phosphorylation of TrkA
and Shc, the association of Shc to Grb2, or the activation of
Ras (measured by glutathione S-transferase–Ras-binding do-
main [GST–RBD] pull-down) induced by NGF in PC12
cells (Fig. 5, A–C; Egea et al., 2000). In this work, we also
analyzed whether NGF-induced PI 3-kinase activity could
require CaM. PC12 cells were treated with W12 or W13,
stimulated for 2 min with NGF, and the PI 3-kinase activity
was measured in antiphosphotyrosine (anti–P-Tyr) immu-
noprecipitates. As shown in Fig. 5 D, PI 3-kinase displayed
an  25-fold activation after NGF stimulation. However,
W13 did not significantly inhibit PI 3-kinase activity when
compared with parallel cultures treated with similar concen-
trations of W12 (Fig. 5 D, graph). Since W13 but not W12
effectively blocked PKB phosphorylation in the same cell ly-
sates (unpublished data; Fig. 1 B), we therefore conclude
that W13 inhibits PKB phosphorylation at some step down-
stream of PI 3-kinase. These experiments were also per-
formed in cultures of MTNs, obtaining similar results. As
shown in Fig. 5 E, W13 did not inhibit the PI 3-kinase ac-
tivity induced by BDNF in MTNs (Fig. 5 E, top panel), de-
spite that in the same cell extracts, the BDNF-induced PKB
phosphorylation was completely prevented by the inhibitor
(Fig. 5 E, bottom panels). Finally, to rule out a direct effect
of W13 on the PI 3-kinase activity of intact cells, we in-
cluded W13 directly in the kinase buffer of PI 3-kinase as-
says. In these experiments, we did not detect any significant
effect of CaM antagonists on the PI 3-kinase activity in-
duced by NGF (unpublished data).
NGF does not require CaM-dependent protein kinase 
kinase to phosphorylate PKB
A recent study reported that the Ca
2 /CaM-dependent pro-
tein kinase kinase (CaMKK) is able to mediate cell survival
by directly phosphorylating and activating PKB (Yano et al.,
1998). To address the involvement of CaMKK in the activa-
Figure 6. CaMKK is not required for the activation of PKB in-
duced by NGF. PC12 cells were transiently transfected with 
pcDNA3-CaMKK
K157A (CaMKK
K157A), empty vector, or left untrans-
fected and then stimulated for 5 min with 5 or 50 ng/ml of NGF as 
indicated. Phosphorylation of Thr
308 and Ser
473 (top panels) of PKB 
was analyzed by Western blot using specific phospho-antibodies. 
Expression of CaMKK
K157A in the same protein lysates was analyzed 
reprobing the filter with a specific antibody against CaMKK (middle 
panel). Protein loading was checked with a specific antibody 
against PKB (bottom panel).592 The Journal of Cell Biology | Volume 154, 2001
tion of PKB induced by NGF, PC12 cells were transfected
with CaMKK
K157A, a dominant negative form of CaMKK
that carries a point mutation in the ATP-binding site (Yano
et al., 1998). These cultures were stimulated for 5 min with
5 or 50 ng/ml of NGF, and PKB activation was analyzed by
Western blot using specific phospho-antibodies. As shown
in Fig. 6, phosphorylation of PKB at the residues Thr
308 and
Ser
473 in cultures transfected with the mutant CaMKK
K157A
was not significantly lower than that observed in control cul-
tures transfected with the empty vector or in nontransfected
cultures. Expression of CaMKK
K157A in transfected cultures
was confirmed by Western blot using an antibody against
CaMKK (Fig. 6). PC12 cells were also transfected with
CaMKK
1–413, a constitutive active form of CaMKK that
lacks the regulatory CaM-binding domain (Enslen et al.,
1996). CaMKK
1–413 did not induced a significant increase in
the phosphorylation of residues Thr
308 or Ser
473 of Akt/PKB
(unpublished data).
CaM antagonists block plasma membrane localization 
of EGFP-PH-PKB
We have shown that CaM antagonists block NT-induced
PKB phosphorylation without affecting the in vitro PI
3-kinase activity. It has been suggested previously that CaM
may be required to detect the products generated by the PI
3-kinase into the plasma membrane of intact cells (Yang et al.,
2000). To analyze this possibility, we transiently transfected
PC12 cells with a construct encoding EGFP fused in frame
with the PH domain of PKB  (EGFP–PKB–PH). After
36 h, cells were treated with W12, W13, or LY294002, stimu-
lated for 20 min with NGF, fixed, and the distribution of
the fluorescence assessed with a confocal microscope. A typi-
cal result is shown in Fig. 7. EGFP–PKB–PH showed a dif-
fuse cytoplasmatic localization in nonstimulated PC12 cells
(Fig. 7, N.S.). However, NGF induced a significant redistri-
bution of the EGFP–PKB–PH fusion protein from the cyto-
sol to the periphery of the cell (Fig. 7, NGF and graph).
Figure 7. CaM antagonists prevent the 
in vivo generation of PtdIns-3,4-P2/
PtdIns-3,4,5-P3 in PC12 cells. PC12 cells 
were transiently transfected with EGFP–
PKB–PH, treated with W12 (70  M), 
W13 (70  M), or LY294002 (50  M), 
and then stimulated for 20 min with 
NGF (50 ng/ml) as indicated. N.S. indi-
cates EGFP-PH-PKB transfected cells 
without any treatment. At the end of the 
treatments, cells were fixed, and EGFP 
distribution was visualized using a laser 
confocal microscope. Laser confocal 
sections through the middle of represen-
tative cells in each treatment are shown. 
Arrows indicate the peripheral redistri-
bution of the EGFP–PKB–PH. The lower 
graph represents the percentage of cells 
displaying plasma membrane fluores-
cence (% positive cells) in each treat-
ment. The values represent the mean   
SEM of two independent experiments. 
*P value using the Student’s t test was 
 0.05 relative to the treatment with 
NGF alone or relative to the treatment 
with NGF plus W12. Bar, 10 mM. Calmodulin modulates neuronal survival | Egea et al. 593
This effect was due to the activation of the PI 3-kinase and
the subsequent generation of PtdIns-3,4-P2/PtdIns-3,4,5-P3
in the plasma membrane, since NGF did not induce any re-
distribution of the fluorescence in PC12 cells transfected
with EGFP alone (unpublished data) and treatment with
LY294002 completely abolished the peripheral distribution
of the EGFP–PKB–PH fusion protein induced by NGF
(Fig. 7, NGF   LY and graph). Cells stimulated with NGF
that have been pretreated with W13 displayed a similar pat-
tern of fluorescence to that observed in nonstimulated cells
or in cells treated with NGF plus LY294002 (Fig. 7, NGF  
W13), reducing significantly the percentage of cells dis-
playing peripheral fluorescence (Fig. 7, graph). This effect
was specific, since W12 did not significantly modify the pe-
ripheral pattern of fluorescence induced by NGF (Fig. 7,
NGF   W12 and graph). Similar experiments were also
performed in EGFP–PKB–PH–transfected MTNs. Con-
focal sections of representative cells treated with BDNF,
BDNF plus W13, BDNF plus LY294002, or left untreated
are shown in Fig. 8. As seen, W13 also abolished the redis-
tribution of the fluorescence to the plasma membrane in
MTNs stimulated with BDNF; this effect is similar to that
observed using LY294002. Therefore, these results suggest
that CaM is involved in the generation and/or stabilization
of PtdIns-3,4-P2/PtdIns-3,4,5-P3 in the plasma membrane
of intact cells.
Discussion
In this study, we report that CaM is necessary for the induc-
tion of cell survival triggered by NGF or BDNF in PC12
cells or MTNs, respectively. Our results demonstrate that
this effect on cell survival is mainly due to the regulation of
PKB activation. Moreover, we have shown that CaM regu-
lates the presence of detectable amounts of PtdIns-3,4-P2/
PtdIns-3,4,5-P3 in the plasma membrane of intact cells thus
providing a possible mechanism whereby CaM regulates the
activation of PKB and the promotion of cell survival.
We have observed that extracellular Ca
2  blockade did
not affect the activation of PKB induced by NGF in PC12
cells thus confirming previous observations obtained in
Balb/c-3T3 fibroblasts stimulated with EGF (Conus et al.,
1998). In contrast, our results point out that intracellular
Ca
2  is completely necessary for the activation of PKB. This
effect seems to be mediated by CaM, since CaM inhibition
mimicked the effects of intracellular Ca
2  blockade on PKB
activation. It has been reported previously that Trk activa-
tion induces a small and rapid increase of [Ca
2 ]i (Jiang and
Guroff, 1997). This is probably achieved through the activa-
tion of PLC  and the subsequent release of Ca
2  from intra-
cellular stores through inositol 1,3,4-triphosphate receptors
(Obermeier et al., 1996). This mechanism seems to partici-
pate in the activation of the ERK MAP kinases, since TrkA
receptors that carry a point mutation in the tyrosine that
binds PLC  (TrkA
Y785F) fail to completely activate these ki-
nases (Stephens et al., 1994). However, it is less clear
whether this IP3-dependent Ca
2  release could participate in
the activation of PKB induced by Trk. For instance, NGF
effectively activates PKB in Rat-1 cells expressing TrkA
Y785F
(Ulrich et al., 1998). Furthermore, the inhibition of IP3 re-
ceptors with the specific inhibitor 2-APB (Maruyama et al.,
1997) does not block the activation of PKB induced by
NGF in PC12 cells (unpublished data). On the basis of
these observations, it is possible that an IP3-independent
mechanism of intracellular Ca
2  release induced by Trk
could be involved in the activation of PKB. Alternatively, it
could be also possible that basal levels of [Ca
2 ]i are required
to activate PKB.
Figure 8. CaM antagonists prevent the in vivo generation of PtdIns-3,4-P2/PtdIns-3,4,5-P3 in MTNs. MTNs cells were transiently transfected 
with EGFP–PKB–PH, treated with W13 (70  M) or LY294002 (50  M), and then stimulated for 20 min with BDNF (50 ng/ml) as indicated. 
N.S. indicates EGFP-PH-PKB–transfected cells without any treatment. At the end of the treatments, cells were fixed, and EGFP distribution was 
visualized using a laser confocal microscope. Laser confocal sections through the middle of representative cells in each treatment are shown. 
Arrows indicate the peripheral redistribution of the EGFP–PKB–PH. Bar, 10 mM.594 The Journal of Cell Biology | Volume 154, 2001
It has been reported that membrane depolarization pro-
motes cell survival in rat sympathetic neurons and granule
neurons through a mechanism involving CaMKII and PI
3-kinase (Hack et al., 1993; Vaillant et al., 1999; Ikegami and
Koike, 2000). However, we have not observed any effect of
KN-62, a specific inhibitor of CaMKII, on the activation of
PKB induced by NGF in PC12 cells (unpublished data). Ac-
cording to this result, it has been reported that KN-62 does
not block cell survival of sympathetic neurons maintained
with NGF (Vaillant et al., 1999; Ikegami and Koike, 2000).
Results obtained in depolarized cerebellar granule neurons
have provided contradictory conclusions regarding the par-
ticipation of the PI 3-kinase in the depolarization-induced
cell survival (D’Mello et al., 1997; Dudek et al., 1997; Miller
et al., 1997). However, it seems clear that depolarization-
induced survival is a CaM-dependent PI 3-kinase-indepen-
dent phenomenon in chicken MTNs (Soler et al., 1998). These
CaM-dependent PI 3-kinase-independent mechanisms have
been attributed recently to the CaMKK. It has been reported
that  N-methyl-D-aspartate–induced increase of [Ca
2 ]i in
NG108 neuroblastoma cells activates CaMKK, which in
turns directly phosphorylates and activates PKB (Yano et al.,
1998). In this study, we have analyzed the participation of
CaMKK in PKB activation, and we have observed that
CaMKK
K157A, a dominant negative form of the enzyme, did
not abolish the activation of PKB induced by NGF, even at
low nonsaturant concentrations of the NT (that is, 5 ng/ml).
Moreover, CaMKK
K157A did not have any effect on NGF-
induced PC12 cell survival (unpublished data). According to
these results, the promotion of cell survival induced by insu-
lin-like growth factor in NG108 neuroblastoma cells was not
affected by CaMKK
K157A (Yano et al., 1998). Together, these
results suggest that the CaM-dependent mechanisms in-
volved in the promotion of cell survival induced by increases
of [Ca
2 ]i (for example, due to membrane depolarization or
Ca
2 -mobilizing agonists) are distinct from those involved in
cell survival promoted by NTs.
To ascertain the mechanism(s) whereby CaM modulates
PKB activity in NT-treated cells, we explored some of the
upstream steps involved in its activation. Neither the phos-
phorylation of Trk or Shc, the interaction of Shc with Grb2,
nor the activation of Ras induced by NGF in PC12 cells re-
quired CaM (Egea et al., 2000). In the present work, we
have also analyzed the activation of PI 3-kinase in anti–
P-Tyr immunoprecipitates in NGF-stimulated PC12 cells and
in BDNF-stimulated MTNs, concluding that it was not af-
fected specifically by the treatment with CaM antagonists.
However, as judged by the lack of peripheral distribution of
the EGFP–PKB–PH fusion protein CaM antagonists did
not allow to detect PtdIns-3,4-P2/PtdIns-3,4,5-P3 in the
plasma membrane of intact cells after NGF and BDNF
stimulation. These apparently contradictory results obtained
using in vitro and in vivo assays have also been observed in
3T3L1 adipocytes. In these cells, CaM antagonists prevent
the presence of PtdIns-3,4-P2/PtdIns-3,4,5-P3 in the plasma
membrane induced by insulin or PDGF without affecting
the PI 3-kinase activity measured in anti–P-Tyr immuno-
precipitates (Yang et al., 2000). Therefore, these results seem
to indicate that CaM is necessary for the generation and/or
stabilization of the PI 3-kinase products. Several mecha-
nisms can account for the role of CaM in this effect. For ex-
ample, it can be possible that CaM exerts a regulation of PI
3-kinase activity in intact cells that is undetectable in the in
vitro kinase assays. Such an explanation has been reported in
the regulation of the PI 3-kinase by Ras. Dominant negative
forms of this GTPase interact with and inhibit the activity of
the PI 3-kinase, but this is only detectable in in vivo assays.
In anti–P-Tyr immunoprecipitates, the interaction is lost,
and therefore the inhibitory effect of the dominant negative
forms of Ras cannot be observed (Rodriguez-Viciana et al.,
1994). Another explanation could be that CaM can be re-
quired for the localization of the PI 3-kinase close to its sub-
strates in intact cells. Indeed, CaM has been involved in the
appropriate intracellular targeting of several proteins such as
Rad or p21(Cip1) (Moyers et al., 1997; Taules et al., 1999).
These hypothesis are supported by recent findings, showing
that both the p85 and p110 subunits of the PI 3-kinase are
able to interact with CaM in a Ca
2 -dependent manner
(Joyal et al., 1997; Fischer et al., 1998). Finally, the possibil-
ity that CaM could negatively regulate the activity of the
phosphatase(s) involved in the downregulation of the prod-
ucts generated by the PI 3-kinase cannot be ruled out. In
this case, the inhibition of CaM would accelerate the disap-
pearance of PtdIns-3,4-P2/PtdIns-3,4,5-P3 from the plasma
membrane.
Our findings have relevant physiological implications in
the developing nervous system. It is well known that in-
creases of [Ca
2 ]i underlying neuronal activity cooperate
with NTs to promote neuronal survival. This phenomenon
ensures that the correct and functional connections will be
selected over the aberrant and nonfunctional ones (Franklin
and Johnson, 1992). This phenomenon can be reproduced
in vitro. For instance, levels of membrane depolarization
that by themselves do not have any trophic effect synergize
with limited amounts of NGF to promote cell survival in
cultures of sympathetic neurons (Vaillant et al., 1999). Our
results suggest a mechanism that could explain the synergis-
tic effect of membrane depolarization on NT-induced cell
survival in which Ca
2  and CaM would sensitize the path-
way involved in the activation of PKB and in the promotion
of cell survival. Moreover, since Ca
2  and CaM are also nec-
essary for the activation of the ERK/MAP kinases induced
by NTs (Egea et al., 2000) we propose that Ca
2  and CaM
play a central role in the regulation of the intracellular sig-
naling pathways activated by NTs.
Materials and methods
Cell culture and cell lysates
PC12 cells were cultured as described (Egea et al., 1999). Chicken spinal
cord MTNs were purified from 5.5-d-old chick embryos (Comella et al.,
1994) with minor modifications described previously (Soler et al., 1998)
and cultured for 48 h in the presence of muscle extract before the treat-
ment with BDNF. For acute stimulations, PC12 cells were serum starved
for 12–15 h, and MTNs were starved of muscle extract for 3–5 h. Inhibitors
were added within the last hour of serum starvation.
Total cell lysates were obtained solubilizing the cells in 2% SDS and
125 mM Tris, pH 6.8, and sonicated. For immunoprecipitations, kinase as-
says, or Ras activity, cells were lysed at 4 C in the adequate lysis buffer
(see below), and nuclei and cellular debris were removed by microfuge
centrifugation. Protein concentration in cell lysates was quantified using
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Plasmids and cell transfection
CaMKK and PKB  cDNAs were cloned from PC12 total RNA using the Ro-
busT reverse transcription-PCR kit (Finnzymes). The dominant negative
form (CaMKK
K157A) and the constitutive active form (CaMKK
1–413) of
CaMKK have been described previously (Enslen et al., 1996; Yano et al.,
1998). CaMKK
K157A point mutant was generated using the QuickChange
Site-directed mutagenesis kit (Stratagene) and sequenced to confirm the
mutation. CaMKK
1–413 was generated by PCR, amplifying the sequence that
codifies for the first 413 amino acids of the protein using the DyNAzyme
EXT DNA polymerase (Finnzymes). NH2-terminally tagged green fluores-
cent protein EGFP–PKB–PH was constructed incorporating a fragment of
750 bp, encoding the first 250 amino acids of PKB  (containing the PH do-
main) with the EGFP as described previously (Currie et al., 1999). All of
the constructs were subcloned into the mammalian expression vector
pcDNA3 (Invitrogen). DNA purification for cell transfection was per-
formed using the QIAGEN Plasmid Maxi kit.
PC12 cells were transfected by electroporation as described in Espinet
et al. (2000). MTNs were transfected 3 h after purification using the Lipo-
fectamine 2000 reagent as suggested by the manufacturer (Life Technolo-
gies). When indicated, PC12 cells or MTNs were cotransfected with
pEGFP (CLONTECH) and pSG5-Gag-PKB, pCMV5-HA-PKB
T308D/S473D, or
the empty vector, using a one to four molar ratio.
Evaluation of cell survival
PC12 cells cultured in serum-containing medium were changed to a se-
rum-free medium containing NGF (10 ng/ml) plus the indicated inhibitors.
After 15 h, cells were fixed and stained with the DNA dye Hoechst 33258
as described previously (Dolcet et al., 1999). When indicated, cells were
also subjected to a TUNEL assay using the in situ cell death detection kit,
TMR red (Roche Diagnostics GmbH). Cell death was expressed as the per-
centage of cells displaying typical nuclear apoptotic morphology or as the
percentage of TUNEL-positive cells. In the EGFP/Gag-PKB or EGFP/HA-
PKB
T308D/S473D cotransfection experiments, treatments started after 36 h of
transfection, and the percentage of apoptotic nuclei in each treatment was
scored in the EGFP-positive cell population.
MTNs maintained for 48 h in the presence of muscle extract were
washed and treated for an additional 24 h in basal medium containing
BDNF (10 ng/ml) plus the indicated inhibitors. At the end of the treat-
ments, cell survival was evaluated as described previously (Soler et al.,
1998) (in the EGFP/Gag-PKB cotransfection experiments, only the EGFP-
positive cells were counted). Alternatively, MTNs were fixed after 15 h of
treatment and subjected to a TUNEL assay and to a Hoechst staining as de-
scribed above.
Western blot and immunoprecipitation
Western blot and immunoprecipitation were performed as described (Egea
et al., 2000). Anti–phospho-Akt-Thr
308 and anti–phospho-Akt-Ser
473 anti-
bodies (New England Biolabs, Inc.), anti-pan ERK, anti-Shc, and anti-CaMKK
(Transduction Laboratories), anti-PKB C-20 (Santa Cruz Biotechnology,
Inc.), anti–P-Tyr (clone 4G10) (Upstate Biotechnology), and anti– -tubulin
(Sigma-Aldrich) were used as suggested by the manufacturer. TrkA immu-
noprecipitation was performed using the antipan–Trk antibody (203) as de-
scribed previously (Becker et al., 1998).
PI 3-kinase assay
PI 3-kinase activity was measured in anti–P-Tyr immunoprecipitates using
L- -phosphatidylinositol as substrate and [ -
32P] ATP (Amersham Pharma-
cia Biotech) as described previously (Egea et al., 1999). Phosphorylated
lipids were resolved in a thin layer chromatography, detected by autora-
diography, and quantified in a PhosphorImager (Boehringer).
Ras activity assay
Activation of Ras was evaluated by a nonradioactive method using the
GST–RBD (de Rooij and Bos, 1997) as described previously (Egea et al.,
2000). Ras was detected using an antipan Ras antibody (Oncogene Re-
search Products).
PKB kinase assay
At the end of treatments, cells were lysed in a buffer containing 1% Triton
X-100, 50 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl,
0.5% NP-40, 1 mM phenylmethylsulfonylfluoride, 10 mg/ml aprotinin, 2
mM benzamidine, 20 mg/ml leupeptin, 1 mM Na3VO4, 40 mM  -glycero-
phosphate, and 25 mM NaF. PKB was immunoprecipitated with the C-20
anti-PKB antibody (Santa Cruz Biotechnology, Inc.) and protein G–Seph-
arose. Immunocomplexes were sequentially washed three times with
lysis buffer, two times with 50 mM Tris, pH 7.5, 100 mM NaCl, 1% Triton
X-100, 1 mM EDTA, two times with 0.5 M LiCl, 100 mM Tris, pH 8.0, 1
mM EDTA, and once with 50 mM Tris, pH 7.4, 10 mM MgCl2. Kinase re-
action was performed at room temperature for 30 min in a kinase buffer
containing 50 mM Tris, pH 7.5, 10 mM MgCl2, and 1 mM DTT supple-
mented with 2.5 mg of histone H2B (Boehringer) and 3 mCi of [ -
32P] ATP
(Amersham Pharmacia Biotech). The reaction was stopped by adding SDS-
PAGE sample buffer. Histone H2B was resolved by SDS-PAGE. Radioac-
tive spots were detected by autoradiography and quantified in a Phos-
phorImager (Boehringer).
Fluorescence microscopy
PC12 cells or MTNs were plated into poliornitine-coated coverslips or into
poliornitine/laminine-coated plates, respectively. Cells were transiently
transfected with the EGFP–PKB–PH construct, and after 36–48 h cells were
starved of trophic support and treated as indicated. At the end of stimula-
tions, the medium was removed, and the cells were fixed in 4% (wt/vol)
paraformaldehyde in PBS (pH 7.4) for 30 min. Cells were washed twice
with PBS and mounted using Vectashield (Vector Laboratories). Images
were scanned on a Leica TCS 4D (PC12 cells) or on a ZEISS LSM 310
(MTNs) laser confocal microscope using an oil immersion objective of
63 . Percentage of cells displaying cell surface fluorescence was obtained
counting 50–100 cells per coverslip using an epifluorescence microscope
with an objective of 40 .
Materials
BAPTA-AM was from Molecular Probes. W5, W7, TFP, and LY294002
were from Calbiochem-Novabiochem. BDNF was from Alomone Labora-
tories. All other reagents were from Sigma-Aldrich. Antipan–Trk (203) and
PC12 cells were a gift from D. Martin-Zanca (CSIC-Universidad de Sala-
manca, Salamanca, Spain). The construct encoding the GST–RBD fusion
protein was a gift from F. McKenzie, (State University of New York, Stony
Brook, NY). pSG5-Gag-PKB was a gift from J. Downward (Imperial Cancer
Research Foundation, London, UK). pCMV5-HA-PKB
T308D/S473D was a gift
from D.R. Alessi (University of Dundee, Scotland, UK) and B.A. Hemmings
(Friedrich Miescher Institute, Basel, Switzerland). 7S NGF was prepared in
our laboratory as described previously (Mobley et al., 1976).
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